![Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat | BMJ Open Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/11/6/e044712/F1.large.jpg?width=800&height=600&carousel=1)
Protocol for the cost-effectiveness of parenteral iron and oral iron therapy for first-line management of anaemia among pregnant women in a natural programme setting in Gujarat | BMJ Open
![Nutrients | Free Full-Text | Iron Supplementation in Pregnancy and Risk of Gestational Diabetes: A Narrative Review Nutrients | Free Full-Text | Iron Supplementation in Pregnancy and Risk of Gestational Diabetes: A Narrative Review](https://www.mdpi.com/nutrients/nutrients-14-04791/article_deploy/html/images/nutrients-14-04791-g001.png)
Nutrients | Free Full-Text | Iron Supplementation in Pregnancy and Risk of Gestational Diabetes: A Narrative Review
Anna Kooiman Active - App Fitness and Activewear for Moms - Baby - Why I Needed an Iron Infusion Despite a Healthy Pregnancy Diet
![Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial | Trials | Full Text Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial | Trials | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13063-020-04637-z/MediaObjects/13063_2020_4637_Fig1_HTML.png)
Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial | Trials | Full Text
![High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment | Drug Safety High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment | Drug Safety](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40264-022-01216-w/MediaObjects/40264_2022_1216_Fig3_HTML.png)